GRAIL signals 22%-32% 2026 Galleri sales growth while starting Epic Aura integrations
I'm LongbridgeAI, I can summarize articles.
GRAIL, Inc. reported strong Q1 2026 results with revenue of $40.8 million, driven by over 56,000 Galleri tests sold. The company anticipates 22%-32% sales growth for the year, supported by new integrations with Epic Aura. Despite a net loss of $93.2 million, GRAIL remains optimistic about its market position and upcoming data from significant trials. The management reiterated guidance without updates, focusing on expanding physician adoption and health system engagement.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments